4//SEC Filing
SHAFFER CHRISTY L 4
Accession 0001209191-17-063617
CIK 0001560241other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:06 PM ET
Size
7.8 KB
Accession
0001209191-17-063617
Insider Transaction Report
Form 4
SHAFFER CHRISTY L
Director
Transactions
- Other
Common Stock
2017-11-30−99,513→ 0 total(indirect: By LLC) - Other
Common Stock
2017-11-30+995→ 995 total(indirect: By LLC)
Footnotes (4)
- [F1]In-kind distribution from L2 Ventures, LLC to its members, without consideration.
- [F2]The Reporting Person is one of the general partners of Hatteras Venture Advisors V, LLC, which is the general partner of L2 Ventures, LLC ("L2 Ventures"). L2 Ventures is the record holder of the securities, and the Reporting Person may be deemed to share voting and dispositive power over the securities held by L2 Ventures. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.
- [F3]In-kind distribution from L2 Ventures, LLC to its members, including Hatteras Venture Advisors V, LLC, without consideration.
- [F4]The Reporting Person is one of the general partners of Hatteras Venture Advisors V, LLC, which is the record holder of the securities, and the Reporting Person may be deemed to share voting and dispositive power over the securities held by Hatteras Venture Advisors V, LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.
Documents
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001145929
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:06 PM ET
- Size
- 7.8 KB